With regard to auditors comment.
Clearly there wasn't an issue with the prior audits carried out by the same auditors so presumably the partner in charge has changed.
Another partner or audit firm could just as easily have made no comment & carried on as before so the distinction is one of a personal view of one individual rather than a failure to comply.
Mngt have stated that even if they had to change valuation they would still disclose the fair value result & use that as their key metric, similar to banks using cash earnings instead of reported.
The company has consistently used the same method for decade+ & generated more cash than they have invested in PCP so there is no issue with regard to the ultimate profitability only the timing of those profits.
So what is the actual consquence to shareholders of a change of methodology other than sp fluctuations?
IMO the biggest potential issue is that you can't pay out dividends without statutory earnings to pay them from, so a potential significant profit write back could restrict future dividend payments at least in the short term.
The issue of operational performance is relatively easily solved based on the prior company performance in the short term however the audit issue could have
a much longer impact.
- Forums
- ASX - By Stock
- PNC
- Ann: 1H19 Media Release
Ann: 1H19 Media Release, page-50
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNC (ASX) to my watchlist
(20min delay)
|
|||||
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $73.69M |
Open | High | Low | Value | Volume |
61.0¢ | 62.0¢ | 60.0¢ | $109.8K | 179.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2071 | 62.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.5¢ | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62500 | 0.480 |
1 | 36200 | 0.470 |
1 | 1816 | 0.465 |
1 | 20000 | 0.460 |
1 | 10000 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 47333 | 1 |
0.500 | 3000 | 1 |
0.505 | 432 | 1 |
0.510 | 85615 | 2 |
0.520 | 904 | 1 |
Last trade - 13.39pm 18/11/2024 (20 minute delay) ? |
Featured News
PNC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online